You should seek urgent medical attention (call 999 or go to A&E) if you experience: Signs of a severe allergic reaction (anaphylaxis): swelling of the face, lips, tongue or throat, difficulty breathing, or a widespread rash Severe or persistent abdominal pain, especially pain radiating to the back, which may suggest pancreatitis You should contact your GP promptly if you experience: Unexplained rapid heart rate or palpitations Significant unintentional weight loss or inability to eat Symptoms of dehydration (dizziness, reduced urine output, extreme thirst) following gastrointestinal illness Any new or worsening symptoms that concern you If you suspect a side effect from any medicine including any treatment received as part of a clinical trial you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk
3,5 A small number of people may notice low mood, flatness, or loss of interest on a GLP-1
Schedule a KLOW Peptide Consultation GoalBMI Wellness offers physician-guided KLOW peptide therapy consultations for eligible adults across New York
January 28, 2025 New Study, More Concern A recent study published in JAMA OtolaryngologyHead & Neck Surgery has added another layer of concern to the growing Noro Nordisk Ozempic lawsuits and the broader litigation over GLP-1 receptor agonists
Finally, although the risk of bias was generally low across studies, sponsorship bias cannot be ruled out given that a substantial proportion of the included RCTs were industry-funded